committee-said
Teva, Allergan win U.S. antitrust approval for generics deal
July 27, 2016 by publisher · Leave a Comment
WASHINGTON (Reuters) – Teva Pharmaceutical Industries Ltd won U.S. antitrust approval to purchase Allergan Plc's generics business, after agreeing to divest 79 generic drugs to rival firms, the Federal Trade Commission said on Wednesday.
More here:
Teva, Allergan win U.S. antitrust approval for generics deal
committee-said
SABMiller pauses AB InBev integration amid new offer
July 27, 2016 by elegant · Leave a Comment
By Martinne Geller LONDON (Reuters) – SABMiller has told employees to pause the integration of its operations with those of Anheuser-Busch InBev as the brewer's board weighs its sweetened takeover offer, two sources familiar with the matter said. “This is another big piece of news to take in and I appreciate this will cause lots of internal and external speculation.
More:
SABMiller pauses AB InBev integration amid new offer
committee-said
Fed keeps rates unchanged, says risks to outlook reduced
July 27, 2016 by elegant · Leave a Comment
The Federal Reserve left interest rates unchanged on Wednesday but said near-term risks to the U.S. economic outlook had diminished, opening the door to a resumption of monetary policy tightening this year. While Fed policymakers said they continued to closely monitor inflation data and global economic and financial developments, they indicated less …
Original post:
Fed keeps rates unchanged, says risks to outlook reduced